REFERENCE
Yip TR, Demaerschalk BM.Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke 38: 1952-1955, No. 6, Jun 2007
Rights and permissions
About this article
Cite this article
Alteplase cost saving following acute ischaemic stroke. Pharmacoecon. Outcomes News 532, 6 (2007). https://doi.org/10.2165/00151234-200705320-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705320-00010